Copyright
©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1291-1300
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1291
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1291
Figure 1 Comparison of the overall survival curves of different groups divided by the prognostic nutritional index.
A: For all patients. The 5-year overall survival rates were 61.8% and 43.4% in the prognostic nutritional index (PNI)-high group and PNI-low group, respectively (P = 0.006); B: For patients with stage T3 or T4 disease (P = 0.001); C: For patients with lymph node metastasis (stage N1-3, P = 0.035); D: For patients with stage TNM III disease (P = 0.035). PNI: Prognostic nutritional index.
Figure 2 Comparison of the disease-free survival curves of different groups divided by the prognostic nutritional index.
A: For all patients, the 5-year disease-free survival rates were 53.5% and 38.3% in the prognostic nutritional index (PNI)-high group and PNI-low group, respectively (P = 0.012); B: For patients with stage T3 or T4 disease (P = 0.002). PNI: Prognostic nutritional index.
- Citation: Sun CY, Zhang XJ, Li Z, Fei H, Li ZF, Zhao DB. Preoperative prognostic nutritional index predicts long-term outcomes of patients with ampullary adenocarcinoma after curative pancreatoduodenectomy. World J Gastrointest Surg 2024; 16(5): 1291-1300
- URL: https://www.wjgnet.com/1948-9366/full/v16/i5/1291.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i5.1291